摘要
骨质疏松症,一种导致骨密度和微结构质量下降的骨病常常与脆性骨折相关,后者对患者和社会造成巨大负担。尽管有几种不同的治疗方法可用于骨质疏松症,如激素替代疗法,双膦酸盐,丹诺沙班和甲状旁腺激素,但对于其长期使用的固有副作用却有一些担忧。寻找替代天然化合物是非常重要的,可以补充克服现有治疗的局限性。在这里,我们回顾了目前关于可能具有骨质疏松症治疗价值的天然化合物的文献。搜索术语包括骨吸收,骨密度,骨质疏松症,绝经后,骨质疏松症或骨密度保护剂,以及与传统,草药,天然疗法,天然健康,饮食或植物雌激素相关的任何术语。包括在审查中的所有化合物和草药都是天然生物活性的或用于民间草药中,并且据报道能够通过各种机制 - 雌激素样活性,抗氧化剂和抗氧化剂在体内或体外减轻骨质减少或骨质疏松症,炎症性质,或通过调节骨质疏松症发病机制中的关键信号通路。通过我们对替代医学的治疗潜力和前景的评估,我们旨在提供一个吸引人的观点,以考虑应用补充的抗骨质疏松治疗选择和骨质疏松症或溶骨性骨病的预防策略。
关键词: 草药,天然化合物,成骨细胞,破骨细胞,骨质疏松症,绝经后骨质疏松症
图形摘要
Current Drug Targets
Title:Therapeutic Potential and Outlook of Alternative Medicine for Osteoporosis
Volume: 18 Issue: 9
关键词: 草药,天然化合物,成骨细胞,破骨细胞,骨质疏松症,绝经后骨质疏松症
摘要: Osteoporosis, a bone disease resulting in the loss of bone density and microstructure quality, is often associated with fragility fractures, and the latter imposes a great burden on the patient and society. Although there are several different treatments available for osteoporosis such as hormone replacement therapy, bisphosphonates, Denosumab, and parathyroid hormone, some concerns have been raised regarding the inherent side effects of their long term use. It would be of great relevance to search for alternative natural compounds, which could complementarily overcome the limitations of the currently available therapy. Herein, we review current literature on natural compounds that might have therapeutic values for osteoporosis. Search terms included bone resorption, bone density, osteoporosis, postmenopausal, osteoporosis or bone density conservation agents, and any of the terms related to traditional, herbal, natural therapy, natural health, diet, or phytoestrogens. All the compounds and herbs included in the review are naturally bioactive or are used in folk herbal medicine and have been reported to be capable of attenuating osteopenia or osteoporosis in vivo or in vitro, through various mechanisms – estrogen-like activity, antioxidant and anti-inflammatory properties, or by modulating the key signaling pathways in the pathogenesis of osteoporosis. Through our assessment of the therapeutic potential and outlook of alternative medicine, we aim to provide an appealing perspective for the consideration of the application of a complementary anti-osteoporotic treatment option and prevention strategy for osteoporosis or osteolytic bone disorders.
Export Options
About this article
Cite this article as:
Therapeutic Potential and Outlook of Alternative Medicine for Osteoporosis, Current Drug Targets 2017; 18 (9) . https://dx.doi.org/10.2174/1389450118666170321105425
DOI https://dx.doi.org/10.2174/1389450118666170321105425 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Chemokine Receptors as Targets for Cancer Therapy
Current Pharmaceutical Design Natural Product-Inspired Synthesis of Thiazolidine and Thiazolidinone Compounds and their Anticancer Activities
Current Pharmaceutical Design Physcion and Physcion 8-O-β-D-glucopyranoside: Natural Anthraquinones with Potential Anticancer Activities
Current Drug Targets Peptides to Target Tumor Vasculature and Lymphatics for Improved Anti-Angiogenesis Therapy
Current Cancer Drug Targets 2-Methoxyestradiol as a Potential Cytostatic Drug in Gliomas?
Anti-Cancer Agents in Medicinal Chemistry MicroRNAs and Bone Regeneration
Current Genomics Ewing’s Sarcoma Cancer Stem Cell Targeted Therapy
Current Stem Cell Research & Therapy Multifunctional RNase MCPIP1 and its Role in Cardiovascular Diseases
Current Medicinal Chemistry Editorial [Hot Topic: The RB-Pathway in Cancer (Executive Editor: Erik Knudsen)]
Current Molecular Medicine New Generation of Liposomal Drugs for Cancer
Anti-Cancer Agents in Medicinal Chemistry Cell Cycle Kinases in Osteosarcoma: Potential for Therapeutic Intervention
Current Pharmaceutical Design Chlorophylls and their Derivatives Used in Food Industry and Medicine
Mini-Reviews in Medicinal Chemistry Effects of Polysaccharides from Selenium-enriched Pyracantha fortuneana on Mice Liver Injury
Medicinal Chemistry Effects of Surface Morphology Variation on the Degradation Rate of Poly(L-Lactic Acid) Membranes and the Behavior of Attached Cells
Micro and Nanosystems The Retinoblastoma Protein in Osteoblast Differentiation and Osteosarcoma
Current Molecular Medicine Meet Our Editorial Board Member
Current Nanomedicine Tumor Targeting with RGD Peptide Ligands-Design of New Molecular Conjugates for Imaging and Therapy of Cancers
Anti-Cancer Agents in Medicinal Chemistry CXCR4 Inhibitors: Tumor Vasculature and Therapeutic Challenges
Recent Patents on Anti-Cancer Drug Discovery Recent Advances in Application of Poly-Epsilon-Caprolactone and its Derivative Copolymers for Controlled Release of Anti-Tumor Drugs
Current Cancer Drug Targets microRNAs in Cancer: Lessons from Melanoma
Current Pharmaceutical Design